Filing Details

Accession Number:
0001209191-22-038713
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-06-22 17:09:25
Reporting Period:
2022-06-17
Accepted Time:
2022-06-22 17:09:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1845337 Day One Biopharmaceuticals Inc. DAWN () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1708269 Atlas Venture Fund Xi, L.p. 300 Technology Square, 8Th Floor
Cambridge MA 02139
No No Yes No
1759241 Atlas Venture Opportunity Fund I, L.p. 300 Technology Square, 8Th Floor
Cambridge MA 02139
No No Yes No
1780065 Atlas Venture Associates Opportunity I, L.p. 300 Technology Square, 8Th Floor
Cambridge MA 02139
No No Yes No
1780066 Atlas Venture Associates Opportunity I, Llc 300 Technology Square, 8Th Floor
Cambridge MA 02139
No No Yes No
1780067 Atlas Venture Associates Xi, Llc 300 Technology Square, 8Th Floor
Cambridge MA 02139
No No Yes No
1780068 Atlas Venture Associates Xi, L.p. 300 Technology Square, 8Th Floor
Cambridge MA 02139
No No Yes No
1885327 Atlas Venture Opportunity Fund Ii, L.p. 300 Technology Square, 8Th Floor
Cambridge MA 02139
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-06-17 766,667 $15.00 766,667 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 7,210,242 Indirect See footnote
Common Stock 15,714 Indirect See footnote
Common Stock 991,396 Indirect See footnote
Footnotes
  1. The shares are held directly by Atlas Venture Opportunity Fund II, L.P. ("AVOF II"). The general partner of AVOF II is Atlas Venture Associates Opportunity II, L.P. ("AVAO II LP"). Atlas Venture Associates Opportunity II, LLC ("AVAO II LLC") is the general partner of AVAO II LP. Each of AVAO II LP and AVAO II LLC disclaims Section 16 beneficial ownership of the securities held by AVOF II, except to the extent of its pecuniary interest therein, if any.
  2. The shares are held directly by Atlas Venture Fund XI, L.P. ("Atlas Venture Fund XI"). The general partner of Atlas Venture Fund XI is Atlas Venture Associates XI, L.P. ("AVA XI LP"). Atlas Venture Associates XI, LLC ("AVA XI LLC") is the general partner of AVA XI LP. Each of AVA XI LP and AVA XI LLC disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Fund XI, except to the extent of its pecuniary interest therein, if any.
  3. The shares are held directly by AVA XI LP. AVA XI LLC is the general partner of AVA XI LP. AVA XI LLC disclaims Section 16 beneficial ownership of the securities held by AVA XI LP, except to the extent of its pecuniary interest therein, if any.
  4. The shares are held directly by Atlas Venture Opportunity Fund I, L.P. ("AVOF I"). The general partner of AVOF I is Atlas Venture Associates Opportunity I, L.P. ("AVAO I LP"). Atlas Venture Associates Opportunity I, LLC ("AVAO I LLC") is the general partner of AVAO I LP. Each of AVAO I LP and AVAO I LLC disclaims Section 16 beneficial ownership of the securities held by AVOF I, except to the extent of its pecuniary interest therein, if any.